Open Access Open Access  Restricted Access Subscription or Fee Access

Implantation of Micropragmata for Diagnosing and Monitoring Heart Attack with Nanorobots and GPS Connectivity

Y. Nancy, A. Shyamala

Abstract


Heart failure, one of the most deadly disorders experienced by people all over the world which has lead to the cause of several unprecedented and unpredictable losses of lives, is yet to be found a solution. Cardiovascular diseases cause 12million deaths per year throughout the world. Though advancements in technology have found many answers, there is still a lack of definite prediction of the attack. The diagnosis and treatment methods adopted today are limited to an acute clinical setting and timing constraints for providing instant relief and action. The lack of timely response to a cardiac event will mean death. Thus, our proposal greatly nullifies the defects in conventional medical practice by incorporating a new innovation of us named micropragmata and the deployment of nanorobots at the site of blocks with the release of the most effective drug called Angioprim. The integration of ASIC and MEMS enable wireless telemetry and processing of pressure measurements to be transmitted at a larger distance, set out to reach a remote physician. For timely action, it is important to locate a patient quickly in order to carry out the emergency operation. Thus the use of GPS renders a helping hand for patient location with the whole of the section involving a central server and a call center at the patient’s service. Thus, the status of the patient’s heart is updated and monitored for further action, incase of major threats which would completely involve the rescue team into action. This methodology will eliminate the pitfalls encountered in modern medical approaches and reverse the intolerable life loss due to heart attack.


Keywords


Angioprim for Dissolving the Arterial Plaque, Central Server, Call Center, Implantation Device (Micropragmata), Nanorobots, etc.

Full Text:

PDF

References


U.C .Hoppe ,M.Vanderheyden, H.Sievert, M.C. Brandet, R.Tobar “Chronic monitoring of pulmonary artery pressure in patients with severe heart failure: Multicentre experience of the monitoring of the pulmonary artery pressure by implantable device responding to ultrasonic signal (PAPYRUS) II Study”, Heart, vol.95, pp.1091-1097, 2009.

M. Fonseca, M. Allen, D. Stern, J. White, and J. Kroh, “Implantable wireless sensor for pressure measurement within the heart,” U.S. Patent 6 855 115, February 15, 2005.

M. Allen, M. Fonseca, J. White, J. Kroh, and D. Stern, Implantable Wire-less Sensor for Blood Pressure Measurement with an Artery. Atlanta, GA: CardioMEMS, Inc., 2005.

J. Joy, J. Kroh, M. Ellis, M. Allen, and W. Pyle, Communicating With Implanted Wireless Sensor. Atlanta, GA: CardioMEMS, Inc., 2007.

Fully Wireless Implantable Cardiovascular Pressure Monitor Integrated with a Medical Stent, Eric Y. Chow∗, Member, IEEE, Arthur L. Chlebowski, Student Member, IEEE, Sudipto Chakraborty, Member, IEEE, William J. Chappell, Member, IEEE, and Pedro P. Irazoqui, Member, IEEE, IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, VOL. 57, NO. 6, JUNE 2010.

Nanotechnology, nanomedicine and nanosurgery, International journal of surgery (2005), Elsevier Ltd.

Biomedical Telemetry: Communication between Implanted devices and the external world by Asimina Kiourti, Opticon 1826, Issue 8, Spring 2010.

Telemedicine: Keeping A Beat On The Heart by Kathy J. Liszka, University of Akron, Michael A. Mackin, Michael J. Lichter, and David W. York, NASA Glenn Research Center, Dilip Pillai and David S, Rosenbaum, Case Western Reserve University.

” On the Ultra Wideband Propagation Channel Characterizations of the Biomedical Implants” Ali Khaleghi (Interventional Centre) Rikhospitalet University Hospital Oslo-Norway, Ilangko Balasingham ,Department of Electronics and Telecommunications ,Norwegian University of Science and Technology (NTNU), Oslo-Norway,2009 IEEE.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.